Pharma companies spent almost $3M on marketing in Vermont for FY 2008
Pharma Compliance Alert, April 22, 2009
Pharmaceutical manufacturers paid almost $3 million to 2,280 doctors, hospitals, universities, and others to market their drugs in fiscal year 2008, according to the Vermont Attorney General’s (AG) sixth annual Report on Pharmaceutical Marketing Disclosures.
Almost half of the reported marketing expenditures were for speaking fees and payments, while nearly 25% was for marketing. Almost 60% of the expenditures were direct payments to recipients in the form of cash or check.
Read more about pharmaceutical marketing disclosures in Vermont.
- Differentiate between types of wound debridement
- Complications from immobility by body system
- Treating Chronic Pain a Tough Task for Physicians
- Note similarities and differences between HCPCS, CPT® codes
- OB services: Coding inside and outside of the package
- Don’t forget the three checks in medication administration
- Fracture coding in ICD-10-CM requires greater specificity
- What does case-mix index mean to you?
- Your Hospital's Financial Statements: How Management Keeps Score
- OSHA issues new inspection guidelines for field inspectors: How you’re affected
- Q&A: HIPAA Notice of Privacy
- Q&A: Review palliative care charts and query for 'comfort care' when appropriate
- Q&A: Coding for palliative care
- Nurse practitioners improve discharges, reduce readmissions, and save hospitals money
- Know How to Document Missed Visits
- Inter-department communication can improve patient safety
- Identify new intraocular lenses for which ASCs can bill patients directly
- ICD-10-CM coma, stroke codes require more specific documentation
- Consider four tips when writing your use-of-force policy
- CMS replaces clinic E/M visit levels with single G-code